Macro observations While this week may be quiet in terms of UK data, there is still one headline event that will have all Sterling traders closely monitoring FX markets. Tuesday sees the UK Chancellor Hammond deliver his Spring statement after reshuffling the Government’s Budget calendar, but it’s not just the dates that have changed. Tuesday’s…

Hikma Pharmaceuticals (HIK), and partner Vectura (VEC), are on the wrong end of the US Food and Drug Administration (FDA) this morning as their bid to challenge GlaxoSmithKline’s asthma combatant hegemony hits another hurdle. The second pushback from the FDA, less than nine months after the US agency found an issue in the clinical endpoint…

2018 has already been a year of ups and downs, with a plethora of stocks rising to trade at multi-year or even all-time highs in January before succumbing to February’s global market correction. However, a number of stocks have continued to follow trends that began in 2017 or earlier, and have extended their channels in…

Many a trader/investor likes to focus on a few names in terms of shares. Sometimes a little too much. It’s never a bad thing to know a bit about the companies we trade. However, shunning the rest of the UK 100 can mean depriving yourself of a plethora of opportunities in other blue-chips which are…

Shares in satellite services operator Inmarsat are 4-5% offside this morning after management capitulated, doing the last thing you want to when trying to keep investors from jumping ship –  slash the dividend – in an effort to preserve cash to help the business bounce back from a tough period by being able to invest…

Just days after the departure of their CFO, Paddy Power Betfair shares are sharply lower this morning as FY results, and more importantly guidance, disappoint shareholders. The betting chain noted that while both revenues and EBITDA grew by 13% and 18%, respectively, above expectations, a string of unfavourable sporting results for punters dented customer activity…